BPC-157: Molecular Characterization and the State of the Literature — A Research Reference

The sequence is glycine-glutamate-proline-proline-proline-glycine-lysine-proline-alanine-aspartate-aspartate-alanine-glycine-leucine-valine, written GEPPPGKPADDAGLV in single-letter code. It is a pentadecapeptide with a molecular weight of approximately 1,419 daltons.

The sequence is described as corresponding to a partial sequence of a protein present in gastric juice, from which the research code derives [1]. It is made by standard solid-phase synthesis rather than expressed, and the synthetic material is a defined chemical entity irrespective of what remains unsettled about its biology.

Two compositional features stand out. Four of the fifteen residues are proline, three of them consecutive at positions 3 through 5 — an unusually proline-dense stretch that constrains backbone geometry substantially and makes the chain stiffer than its length alone would suggest. And the composition contains no cysteine, no methionine, no tryptophan and no asparagine or glutamine, which removes essentially every common chemical degradation route at once. By composition this is among the most chemically robust sequences in the catalogue.

This is the section that matters most for anyone assessing the compound, and it warrants directness.

No receptor or molecular target has been identified. There is no binding assay to run, no transducer to measure, and no structural model of a ligand-target complex to reason from. Published work is phenomenological — describing observed effects in model systems — rather than mechanistic.

No structural biology has been published. There is no crystal structure, no NMR solution structure, and no published conformational analysis of the peptide, despite the proline-rich composition that would make such a study informative. The structural claims that can be made about this molecule are the ones derivable from its sequence, and no more.

The literature is concentrated and unevenly indexed. A substantial proportion of published work on this compound originates from a single research group, and much of it appears in conference abstracts, supplement issues and journals with limited international indexing. Independent replication from unaffiliated laboratories is sparse. A review in the indexed literature has summarized reported findings in the musculoskeletal soft tissue context [1], but it summarizes that same concentrated body of work rather than adding independent characterization.

None of this establishes that reported observations are wrong. It establishes that the evidence base is narrower and less independently corroborated than for most compounds in this catalogue, and that claims encountered elsewhere should be weighed against that. A researcher choosing this compound should do so knowing the mechanistic groundwork has not been laid.

Whatever remains unsettled about the biology, the analytical position is straightforward — the molecule is a defined fifteen-residue sequence and is verified as such.

Mass spectrometry confirms the intact molecular mass near 1,419 daltons.

Reversed-phase HPLC resolves the main peak from related substances and yields the purity figure. In a fifteen-residue synthesis the dominant related substances are deletion sequences, where a residue failed to couple; these differ from the target by one amino acid and can elute close to it, which is why the trace is more informative than the headline percentage.

Two sequence-specific considerations apply. Proline-rich chains present as slowly interconverting conformers, appearing on a chromatogram as broadened or split peaks rather than as genuine impurities — distinguishing a conformational artefact from a real contaminant is a question the trace answers. And the two consecutive aspartates at positions 10 and 11 make the sequence susceptible to aspartimide formation, in which an aspartate side chain cyclizes onto the backbone and can reopen as iso-aspartate — a structural isomer of identical mass, invisible to mass spectrometry at any resolution and separable only chromatographically.

The composition contains no aromatic residues, so absorbance at 280 nanometres is negligible and detection relies on backbone absorbance near 214 nanometres instead.

Net peptide content accounts for counter-ions and residual water, determining how much peptide a nominal milligram figure represents.

Sealed lyophilized material is stable at ambient temperature for the duration of transit and requires no cold chain in shipping. On receipt, vials are refrigerated and kept out of direct light.

Reconstituted material is held refrigerated and used within the window the receiving facility's protocols specify, and repeated freeze-thaw cycling is avoided.

The absence of cysteine, methionine, tryptophan, asparagine and glutamine removes oxidation, photosensitivity and deamidation as concerns — an unusually clean profile. The residual consideration is the aspartimide route described above, which is not confined to synthesis: the same rearrangement proceeds slowly in solution and faster at alkaline pH, so a peptide clean at manufacture can accumulate the isomer while sitting in a tube. Making solutions up as needed is the mitigation.

BPC-157 is an investigational compound. It has not been approved by the FDA or any other regulatory authority, and no manufacturing, labeling, or quality standards for an approved product apply to it. Research material is sold strictly for laboratory research use; it must not be administered to humans or animals. Researchers are responsible for compliance with all institutional and jurisdictional requirements governing research chemicals.

Each batch of research-grade BPC-157 is accompanied by an independent certificate of analysis specific to that lot.

BPC-157 is a pentadecapeptide of approximately 1,419 daltons, GEPPPGKPADDAGLV, described as corresponding to a partial sequence of a gastric juice protein. Its composition — proline-dense, and free of cysteine, methionine, tryptophan, asparagine and glutamine — makes it among the most chemically robust sequences in the catalogue. No receptor or molecular target has been identified, no structural biology has been published, and the literature is concentrated in a single research group with limited independent replication. Analytical verification is nonetheless straightforward: mass confirmation, chromatographic resolution of deletion sequences and the mass-identical iso-aspartate isomer, detection at 214 nanometres, and batch-specific net peptide content.